Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Jaeb Center for Health Research
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Both cohorts match by age, gender, race and CFTR genotype severity.
You may not be if
No prior solid organ transplantation
No initiation of an investigation drug within 28 days prior to and including Baseline Visit.
No initiation of new chronic therapy (e.g., ibuprofen, azithromycin, inhaled tobramycin, Cayston, CFTR modulator, etc.) within 28 days prior to and including Baseline visit.
No acute use of antibiotics (oral, inhaled or IV) or acute use of systemic corticosteroids for respiratory tract symptoms within 14 days prior to and including Baseline visit.
For the BIA sub-study - Individuals with an implanted pacemaker will be excluded.
No initiation of a drug for weight loss (such as a GLP-1 receptor agonist) or bariatric surgery within 6-months prior to and including the Baseline visit.
Patients with continued rapid change or extreme GI symptoms related to weight loss therapy should be excluded at the discretion of the study investigator.
Clareo Health | Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
